Citation Impact
Citing Papers
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters
2005
The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage
2004
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters
2004
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
2006
Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral-spinal fluid barrier by in vivo biotinylation
2008
Expression of Multidrug Resistance Associated Protein 5 (MRP5) on Cornea and Its Role in Drug Efflux
2009
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
2010
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
From traditional Chinese medicine to rational cancer therapy
2007 Standout
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Doxorubicin pathways
2010 Standout
Drugs as CYP3A Probes, Inducers, and Inhibitors
2007
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Natural products: An evolving role in future drug discovery
2011 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Structure and function of the blood–brain barrier
2009 Standout
Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
2010
Reference glycan structure libraries of primary human cardiomyocytes and pluripotent stem cell-derived cardiomyocytes reveal cell-type and culture stage-specific glycan phenotypes
2020
Glioblastoma and Other Malignant Gliomas
2013 Standout
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Ocular Drug Delivery
2010 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Performance comparison of a co-crystal of carbamazepine with marketed product
2006
Effect ofMDR1C3435T polymorphism on cure rates ofHelicobacter pyloriinfection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation toCYP 2C19 genotypes and 23S rRNA genotypes ofH. pylori
2007
Impact of P-glycoprotein on clopidogrel absorption
2006
Molecular Pharmacokinetics of Catharanthus (Vinca) Alkaloids
2007
Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy
2007
Clinically relevant drug interactions with antiepileptic drugs
2005
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable Epilepsy
2005
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Targeting multidrug resistance in cancer
2006 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
2008
MDR1 haplotypes significantly minimize intracellular uptake and transcellular P‐gp substrate transport in recombinant LLC‐PK1 cells
2006
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
2011
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
2007
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
2010
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Photodynamic therapy of cancer: An update
2011 Standout
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
2005
Multidrug resistance 1 gene in inflammatory bowel disease: A meta-analysis
2006
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Natural compounds for cancer treatment and prevention
2009 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
2010
Preservation of Fertility in Patients with Cancer
2009 Standout
Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients
2003
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pharmaceutical Cocrystals and Their Physicochemical Properties
2009 Standout
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
The Pharmacogenetics of Calcineurin Inhibitors: One Step Closer Toward Individualized Immunosuppression?
2005
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Anthracycline Cardiotoxicity: From Bench to Bedside
2008
Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P‐glycoprotein up‐regulation at the blood‐brain barrier
2008
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
2005
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Drug Solubility: Importance and Enhancement Techniques
2012 Standout
An introduction to the metabolic determinants of anthracycline cardiotoxicity
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Compartmentalization of Cardiac β-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5
2007
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
2011 Standout
Solubility Advantage of Pharmaceutical Cocrystals
2009 Standout
Association of Cumulative Cyclosporine Dose with Its Irreversible Nephrotoxicity in Japanese Patients with Pediatric-Onset Autoimmune Diseases
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #
2009
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Update on rifampin, rifabutin, and rifapentine drug interactions
2012
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
2011
Implications of ATP-binding cassette transporters for brain pharmacotherapies
2007
Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
2009
The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2
2007
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites
2005
Works of Peter Dazert being referenced
CYP2D6genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects
2004
Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats
2006
Expression and Localization of the Multidrug Resistance Protein 5 (MRP5/ABCC5), a Cellular Export Pump for Cyclic Nucleotides, in Human Heart
2003
Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms
2004
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans
2004
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex
2006
Expression and Localization of P-glycoprotein in Human Heart
2002
The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol
2002
The ATP-binding Cassette Transporter ABCG2 (BCRP), a Marker for Side Population Stem Cells, Is Expressed in Human Heart
2005